Selective Induction of Estrogen Conjugative Metabolism
选择性诱导雌激素结合代谢
基本信息
- 批准号:7024997
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-03-01 至 2006-12-31
- 项目状态:已结题
- 来源:
- 关键词:benzoatesbreast neoplasmscancer preventionchemical conjugateenzyme activityenzyme induction /repressionenzyme mechanismestradiolestrogenshigh performance liquid chromatographyhormone metabolismhormone related neoplasm /cancerhydroxylationimmunocytochemistrylaboratory ratnorthern blottingsoxidationsulfationtissue /cell culture
项目摘要
DESCRIPTION (provided by applicant): This proposal is aimed at testing a novel hypothesis that chemicals that can preferentially stimulate the metabolic conversion of estradiol (E2) and its hydroxylated metabolites (such as 4-OH-E2 and 16alpha-OH-E1) to inactive, water-soluble conjugates would be better and safer inhibitors of E2-induced cancer than inducers of estrogen oxidative metabolism. On the basis of our recent data on the preferential stimulatory effect of dietary dibenzoylmethane (DAM) on E2 conjugative metabolism in human mammary cells and in animals, we propose the following four Specific Aims for our initial testing of this novel hypothesis. Aim 1: To study dietary DBM and its analogs for their activity in inducing the enzymes for estrogen conjugation (glucuronidation, sulfation, and O-methylation) vs oxidation in non-neoplastic AG11134 human mammary epithelial cells by using biochemical assays and Northern blot analysis. Aim 2: To study strong dietary inducers identified under Aim 1 for their activity in inducing estrogen conjugation in liver, breast, and uterus of female ACI rats. Aim 3: To compare the effects of strong inducers of estrogen conjugation with indole-3-carbinol (a prototypical dietary inducer of estrogen oxidation) on the metabolic fate of E2 and 4-OH-E2 (a representative bioactive hydroxyestrogen metabolite) in blood and target organs of female ACI rats. Aim 4: To compare the effects of an identified inducer of estrogen conjugative metabolism with indole-3-carbinol on the mitogenic actions of E2 and 4-OH-E2 in the breast and uterus of female rats, and to compare their efficacies in the prevention of estrogen-induced mammary tumors in female ACI rats. We predict that an inducer of estrogen conjugative metabolism will have a much higher cancer-preventive efficacy than an inducer of estrogen oxidative metabolism under conditions where estrogen's hormonal activity is equally inhibited. These hypothesis-driven, mechanism-based studies will lead to the development of an effective, novel strategy for dietary or phytochemical-based prevention of estrogen-induced human cancers. These studies will also provide examinations of the important roles of bioactive estrogen metabolites (e.g., 4-OH-E2 and 16alpha-OH-E2) in estrogen-induced cancers.
描述(由申请人提供):该提案旨在测试一种新的假设,即可以优先刺激雌二醇(E2)及其羟基代谢物的代谢转化的化学物质(例如4-OH-E2和16Alpha-OH-E1)比无效的,水的conjugate和Sajugation concointy和Sajugation相比,e eTRINIS的eTROINGER eTRINIS的eTCORTIONS比氧化代谢。根据我们最近关于饮食中二苯甲酰甲烷(DAM)对人类乳腺细胞和动物中E2结合代谢的优先刺激作用的数据,我们提出了以下四个特定目的,用于初步测试这一新假设。目的1:研究饮食DBM及其类似物,用于诱导雌激素结合酶的活性(葡萄糖醛酸化,硫酸化和O-甲基化)与非偏神经AG11134人类乳腺上皮细胞中的非肿瘤AG11134中的氧化相对于氧化。目标2:研究在AIM 1下鉴定出的强大饮食诱导剂,以使其在雌性ACI大鼠的肝脏,乳房和子宫中诱导雌激素结合的活性。目标3:要比较雌激素结合的强诱导剂与吲哚-3-甲醇(雌激素氧化的典型饮食诱导剂)对血液和靶标的Organs的E2和4-OH-E2代谢命运(一种代表性的生物活性羟基代谢物)的影响。目标4:比较鉴定出雌激素结合代谢的诱导剂与吲哚-3-甲醇对E2和4-OH-E2在雌性大鼠的乳房和子宫中的有丝分裂作用的影响,并比较其在预防雌激素诱导的雌性乳腺肿瘤中的效果。我们预测,在雌激素的激素活性同样抑制的情况下,雌激素结合代谢的诱导剂将比雌激素氧化代谢的诱导剂具有更高的癌症疗效。这些基于假设驱动的基于机制的研究将导致发展有效的,新的基于饮食或植物化学的预防雌激素诱导的人类癌症的策略。这些研究还将提供对生物活性雌激素代谢产物(例如4-OH-E2和16alpha-OH-e2)在雌激素诱导的癌症中的重要作用的检查。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BAO-TING ZHU其他文献
BAO-TING ZHU的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BAO-TING ZHU', 18)}}的其他基金
Dietary Polyphenols Are Consequential Epigenetic Modulators of Gene Expression
膳食多酚是基因表达的重要表观遗传调节剂
- 批准号:
7434725 - 财政年份:2006
- 资助金额:
-- - 项目类别:
Dietary Polyphenols Are Consequential Epigenetic Modulators of Gene Expression
膳食多酚是基因表达的重要表观遗传调节剂
- 批准号:
7289336 - 财政年份:2006
- 资助金额:
-- - 项目类别:
Dietary Polyphenols Are Consequential Epigenetic Modulators of Gene Expression
膳食多酚是基因表达的重要表观遗传调节剂
- 批准号:
7645082 - 财政年份:2006
- 资助金额:
-- - 项目类别:
Dietary Polyphenols Are Consequential Epigenetic Modulators of Gene Expression
膳食多酚是基因表达的重要表观遗传调节剂
- 批准号:
7455988 - 财政年份:2006
- 资助金额:
-- - 项目类别:
Selective Induction of Estrogen Conjugative Metabolism
选择性诱导雌激素结合代谢
- 批准号:
6853607 - 财政年份:2003
- 资助金额:
-- - 项目类别:
相似国自然基金
解毒三根汤基于β-catenin/ZEB1逆转AKT抑制剂诱导AKT1 E17K突变乳腺癌EMT的协同增效机制研究
- 批准号:82305336
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于磁共振APT成像的乳腺癌新辅助治疗敏感性预测研究
- 批准号:82302153
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
海洋来源二倍半萜MHO7靶向整合素β8/TGF-β轴调控EMT抑制三阴性乳腺癌转移的作用机制研究
- 批准号:82304550
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
SGK3/BECN1信号促进自噬介导乳腺癌对他莫昔芬耐药机制研究
- 批准号:82373901
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
调控线粒体钙失稳纳米信使联合自噬抑制用于乳腺癌的信号级联可视化治疗研究
- 批准号:82302210
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Gut microbiome-mediated differences within the pre-malignant mammary tissue environment enhance early breast tumor metastasis
恶变前乳腺组织环境中肠道微生物介导的差异增强了早期乳腺肿瘤转移
- 批准号:
10594667 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Crosslinking-based targeted therapy for triple-negative breast cancer
基于交联的三阴性乳腺癌靶向治疗
- 批准号:
10650998 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Elucidating novel epigenetic modifications implicated in multiple myeloma risk disparities
阐明与多发性骨髓瘤风险差异相关的新型表观遗传修饰
- 批准号:
10912191 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Dual action immunostimulatory nanoparticles for treatment of aggressive cancers
用于治疗侵袭性癌症的双重作用免疫刺激纳米颗粒
- 批准号:
10618487 - 财政年份:2023
- 资助金额:
-- - 项目类别:
The Meharry Cancer Summer Research Program (SuRP)
梅哈里癌症夏季研究计划 (SuRP)
- 批准号:
10715291 - 财政年份:2023
- 资助金额:
-- - 项目类别: